TR200000249T2 - Transdermal therapeutic system (TTS) for the passage of an active substance into an organism and its application to the skin - Google Patents

Transdermal therapeutic system (TTS) for the passage of an active substance into an organism and its application to the skin

Info

Publication number
TR200000249T2
TR200000249T2 TR2000/00249T TR200000249T TR200000249T2 TR 200000249 T2 TR200000249 T2 TR 200000249T2 TR 2000/00249 T TR2000/00249 T TR 2000/00249T TR 200000249 T TR200000249 T TR 200000249T TR 200000249 T2 TR200000249 T2 TR 200000249T2
Authority
TR
Turkey
Prior art keywords
skin
active substance
application
tts
therapeutic system
Prior art date
Application number
TR2000/00249T
Other languages
Turkish (tr)
Inventor
Von Kleinsorgen Reinhard
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of TR200000249T2 publication Critical patent/TR200000249T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bir etki maddesinin deri üzerinden insani veya hayvani bir organizmaya geçirilmesi için, etki maddesini içeren karisimi (5), uygulamadan önce çikarilabilen koruma tabakasi (11) da bulunan, ve örtülebilen bir aktif tabakayi (2), ve karisimi (5) disariya karsi sinirlayan ve etki maddesini geçirmeyen örtme tabakasini (1)'da kapsayan transdermal terapötik sistemin ( TTS) özelligi, karisimin (5) aktif tabakasinin (2) uygulama aninda deriye dönük etki maddesi bulunan yüzeyinin kismi bir bölgesinin (6) etki maddesi geçirmeyen bir kapali tabaka (3) ile örtülü olmasidir.In order to transfer an active substance through the skin to a human or animal organism, the mixture containing the active substance (5), an active layer (2), which can also be removed before application, and which covers the mixture (5) against the outside, and The feature of the transdermal therapeutic system (TTS), which includes the impermeable cover layer (1), is an impermeable cover layer (3) of a part of the surface (6) of the active layer (2) of the mixture with the skin-facing agent at the time of application. ) is covered by.

TR2000/00249T 1997-08-06 1998-08-01 Transdermal therapeutic system (TTS) for the passage of an active substance into an organism and its application to the skin TR200000249T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19733981A DE19733981A1 (en) 1997-08-06 1997-08-06 Transdermal therapeutic system (TTS) for the delivery of active ingredient through the skin to an organism and method for application to the skin

Publications (1)

Publication Number Publication Date
TR200000249T2 true TR200000249T2 (en) 2000-08-21

Family

ID=7838128

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00249T TR200000249T2 (en) 1997-08-06 1998-08-01 Transdermal therapeutic system (TTS) for the passage of an active substance into an organism and its application to the skin

Country Status (16)

Country Link
EP (1) EP0986374A2 (en)
JP (1) JP2002517379A (en)
KR (1) KR20010022629A (en)
AU (1) AU737115B2 (en)
CA (1) CA2298442A1 (en)
DE (1) DE19733981A1 (en)
HU (1) HUP0003347A3 (en)
ID (1) ID24195A (en)
IL (1) IL134007A0 (en)
NO (1) NO20000376D0 (en)
NZ (1) NZ502405A (en)
PL (1) PL338793A1 (en)
SK (1) SK1482000A3 (en)
TR (1) TR200000249T2 (en)
WO (1) WO1999007349A2 (en)
ZA (1) ZA987006B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027258C1 (en) 2000-05-31 2001-10-31 Lohmann Therapie Syst Lts Transdermal therapeutic system, for local/systemic delivery of non-steroidal antiinflammatory agents, comprises a permeable, elastic water and air permeable backing layer and an impermeable two-phase drug-containing matrix layer
DE10056014A1 (en) * 2000-11-11 2002-05-16 Beiersdorf Ag Laminated plaster with active substance, used as transdermal therapeutic system, has impermeable barrier layer on side away from skin and separable carrier layer with adhesive on side towards skin
CN101380258B (en) 2001-11-23 2013-09-18 科洛普拉斯特公司 A wound dressing
DE102004020463A1 (en) * 2004-04-26 2005-11-10 Grünenthal GmbH Drug delivery system consisting of a drug-containing patch and at least one Wirkstoffabgaberegulierungsmittel
DE202005014347U1 (en) 2005-09-09 2007-01-18 Grünenthal GmbH Application system for a medicated plaster and Wirkstoffgabgaberegulierungsmittel
HU0900117D0 (en) 2009-02-26 2009-04-28 Genetic Immunity Kutatasi Topical or transdermal delivery kit
DE102017125281A1 (en) 2017-10-27 2019-05-02 Dermatools Biotech Gmbh Device for providing a skin or wound dressing
DE102018216244A1 (en) 2018-09-24 2020-03-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system with barrier layer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340190C (en) * 1988-08-01 1998-12-15 The Kendall Company Discontinuous adhesive surface
DE3908431A1 (en) * 1989-03-15 1990-09-27 Lohmann Therapie Syst Lts TRANSDERMAL SYSTEM WITH STAGE SUBSTANCE DELIVERY AND USE FOR LOCAL OR SYSTEMIC DISPENSER
EP0593807A1 (en) * 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
DE19503336C2 (en) * 1995-02-02 1998-07-30 Lohmann Therapie Syst Lts Pharmaceutical form for delivering active substances to wounds, process for their preparation and their use
AU6698196A (en) * 1995-08-15 1997-03-12 Universite Libre De Bruxelles Liposomes preparation method and plant
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion

Also Published As

Publication number Publication date
JP2002517379A (en) 2002-06-18
HUP0003347A2 (en) 2001-02-28
IL134007A0 (en) 2001-04-30
WO1999007349A2 (en) 1999-02-18
AU9434498A (en) 1999-03-01
PL338793A1 (en) 2000-11-20
HUP0003347A3 (en) 2001-04-28
KR20010022629A (en) 2001-03-26
CA2298442A1 (en) 1999-02-18
ID24195A (en) 2000-07-13
NO20000376L (en) 2000-01-25
EP0986374A2 (en) 2000-03-22
AU737115B2 (en) 2001-08-09
DE19733981A1 (en) 1999-02-11
NZ502405A (en) 2001-01-26
SK1482000A3 (en) 2000-07-11
WO1999007349A3 (en) 1999-08-05
ZA987006B (en) 1999-02-08
NO20000376D0 (en) 2000-01-25

Similar Documents

Publication Publication Date Title
KR910009264A (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
EA200000267A1 (en) DELIVERY DEVICE FOR LONG-TERM DELIVERY OF MEDICINES
DE3584766D1 (en) TRANSDERMAL SYSTEM FOR TIMOLOL.
ZA803009B (en) Transdermal release system for pharmaceutical preparations
NO20001003D0 (en) Transdermal therapeutic system comprising a pressure sensitive adhesive reservoir layer and a unidirectional elastic cover layer
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
DE3876756D1 (en) DEVICE FOR CONTROLLED RELEASE AND ADMINISTRATION OF ACTIVE SUBSTANCES TO ANIMAL TISSUE.
DE59902270D1 (en) HUMIDITY-ACTIVATED THERAPEUTIC SYSTEM
WO1997004818A3 (en) Transdermal therapeutic sysgtem for administering active agents to the human body via the skin
ATE146071T1 (en) SWEAT-INHIBITANT AGENT
NZ509215A (en) Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels
ES2012158A6 (en) Liposomes containing active substance for regulating tanning of the skin
IE873120L (en) User-activated transdermal therapeutic system
GB2076660A (en) Application unit for epicutaneous testing or treatment
AU4739089A (en) Superficial therapeutic system comprising an anti-neoplastic active substance, particularly 5-fluorouracil
NO20000376D0 (en) Transdermal therapeutic system for releasing active substance through the skin into an organism and method of application to the skin
DE59506962D1 (en) ESTRADIOL TTS WITH WATER-BINDING ADDITIVES
HUT43959A (en) Medical plasters containing non-continous adhesive layer suitable for getting in therapeutic active agents into skin or through the skin into organism
DE3883044D1 (en) TUMOR FIGHTING ACTIVE SUBSTANCE.
DE59509643D1 (en) TRANSDERMAL THERAPEUTIC SYSTEM WITH HYDROLYSIS PROTECTION
ES2017282A6 (en) Dressing for transcutaneous application of active substances for therapeutic or cosmetic purposes.
TR200100020T2 (en) Composition, manufacturing methods and use of glycerol trinitrate content
ATE36333T1 (en) HYDANTOIN CONTAINING THERAPEUTIC AGENT.
HK1026846A (en) Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin
NO981020D0 (en) Transdermal therapeutic system for silatran compounds